• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

六种不同粪便钙卫蛋白检测方法在炎症性肠病中的分析性能和诊断准确性

Analytical performance and diagnostic accuracy of six different faecal calprotectin assays in inflammatory bowel disease.

作者信息

Oyaert Matthijs, Boel An, Jacobs Julie, Van den Bremt Stefanie, De Sloovere Maxime, Vanpoucke Hilde, Van Hoovels Lieve

机构信息

.

出版信息

Clin Chem Lab Med. 2017 Aug 28;55(10):1564-1573. doi: 10.1515/cclm-2016-1012.

DOI:10.1515/cclm-2016-1012
PMID:28222018
Abstract

BACKGROUND

We evaluated the analytical performance of six different faecal calprotectin immunoassays together with their diagnostic accuracy in the discrimination between functional and organic bowel disorders.

METHODS

The faecal samples were obtained from inflammatory bowel disease patients (n=27) at the time of diagnosis [Crohn's disease (n=15), colitis ulcerosa (n=12)], gastroenterologic disease control patients (n=52) and rheumatologic disease control patients (n=26). All individuals included in the study underwent a concurrent ileocolonoscopy. Analytical performance (imprecision, accuracy, carry-over, correlation and agreement) and diagnostic accuracy (sensitivity, specificity, likelihood ratios) of the different assays were evaluated.

RESULTS

All methods demonstrated good analytical performance, but within-run and total imprecision varied depending on the assay methodology used. Using Passing Bablok and Bland-Altman analyses, low quantitative agreement was observed between the assays. All assays showed excellent diagnostic accuracy, with areas under the receiver operating characteristic curves (ROC) ranging from 0.974 to 0.998. The AUCs were not significantly different between assays (p>0.05). Diagnostic sensitivity at the cut-off at a fixed specificity of 75% ranged from 95.2% to 100%. Introduction of multiple result intervals increased the clinical interpretation of all the assays.

CONCLUSIONS

Analytical and diagnostic performance of the evaluated faecal calprotectin assays is good, but numerical values differ substantially between the assays necessitating the use of different clinical cut-offs. Introduction of multiple result intervals aids in clinical decision-making.

摘要

背景

我们评估了六种不同的粪便钙卫蛋白免疫测定法的分析性能及其在区分功能性和器质性肠道疾病中的诊断准确性。

方法

粪便样本取自炎症性肠病患者(n = 27)确诊时[克罗恩病(n = 15),溃疡性结肠炎(n = 12)]、胃肠病对照患者(n = 52)和风湿病对照患者(n = 26)。纳入研究的所有个体均同时接受了回结肠镜检查。评估了不同测定法的分析性能(不精密度、准确性、携带污染、相关性和一致性)和诊断准确性(敏感性、特异性、似然比)。

结果

所有方法均显示出良好的分析性能,但批内和总不精密度因所使用的测定方法而异。使用Passing Bablok分析和Bland-Altman分析,各测定法之间观察到低定量一致性。所有测定法均显示出优异的诊断准确性,受试者工作特征曲线(ROC)下面积范围为0.974至0.998。各测定法之间的AUC无显著差异(p>0.05)。在固定特异性为75%时的诊断敏感性范围为95.2%至100%。引入多个结果区间增加了所有测定法的临床解读。

结论

所评估的粪便钙卫蛋白测定法的分析和诊断性能良好,但各测定法的数值差异很大,因此需要使用不同的临床临界值。引入多个结果区间有助于临床决策。

相似文献

1
Analytical performance and diagnostic accuracy of six different faecal calprotectin assays in inflammatory bowel disease.六种不同粪便钙卫蛋白检测方法在炎症性肠病中的分析性能和诊断准确性
Clin Chem Lab Med. 2017 Aug 28;55(10):1564-1573. doi: 10.1515/cclm-2016-1012.
2
Comparison of two immunoassays for measurement of faecal calprotectin in detection of inflammatory bowel disease: (pre)-analytical and diagnostic performance characteristics.两种免疫分析法检测粪便钙卫蛋白在炎症性肠病诊断中的比较:(分析前)和诊断性能特征。
Clin Chem Lab Med. 2014 Mar;52(3):391-7. doi: 10.1515/cclm-2013-0699.
3
Analytical and diagnostic performance of two automated fecal calprotectin immunoassays for detection of inflammatory bowel disease.两种用于检测炎症性肠病的自动粪便钙卫蛋白免疫测定法的分析和诊断性能
Clin Chem Lab Med. 2017 Aug 28;55(9):1435-1446. doi: 10.1515/cclm-2016-0796.
4
Effect of faecal calprotectin assay variability on the management of inflammatory bowel disease and potential role of faecal S100A12.粪便钙卫蛋白检测变异性对炎症性肠病管理的影响及粪便S100A12的潜在作用
J Clin Pathol. 2017 Dec;70(12):1049-1056. doi: 10.1136/jclinpath-2017-204340. Epub 2017 Jul 22.
5
Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year.抗肿瘤坏死因子α制剂诱导治疗炎症性肠病后粪便钙卫蛋白检测:一年时临床反应和黏膜愈合的预测
Dig Liver Dis. 2014 Nov;46(11):974-9. doi: 10.1016/j.dld.2014.07.013. Epub 2014 Aug 2.
6
Faecal calprotectin, an useful marker in discriminating between inflammatory bowel disease and functional gastrointestinal disorders.粪便钙卫蛋白是区分炎症性肠病和功能性胃肠疾病的有用标志物。
Gastroenterol Hepatol. 2017 Mar;40(3):125-131. doi: 10.1016/j.gastrohep.2016.04.009. Epub 2016 May 31.
7
[Calprotectin levels in patients with idiopathic inflammatory bowel disease comparison of two commercial tests].[特发性炎症性肠病患者的钙卫蛋白水平:两种商业检测方法的比较]
Epidemiol Mikrobiol Imunol. 2008 Nov;57(4):147-53.
8
Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease.关于粪便钙卫蛋白作为炎症性肠病生物学标志物作用的问答
Dig Liver Dis. 2009 Jan;41(1):56-66. doi: 10.1016/j.dld.2008.05.008. Epub 2008 Jul 3.
9
Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome.粪便钙卫蛋白作为区分炎症性肠病和肠易激综合征的新型生物标志物。
Mol Med Rep. 2014 Jul;10(1):522-6. doi: 10.3892/mmr.2014.2180. Epub 2014 Apr 24.
10
Clinical importance of faecal calprotectin variability in inflammatory bowel disease: intra-individual variability and standardisation of sampling procedure.粪便钙卫蛋白变异性在炎症性肠病中的临床重要性:个体内变异性及采样程序的标准化
Scand J Gastroenterol. 2016;51(5):548-55. doi: 10.3109/00365521.2015.1117650. Epub 2015 Dec 4.

引用本文的文献

1
Validation of rapid fecal calprotectin assay using particle enhanced turbidimetric immunoassay for inflammatory bowel disease.基于胶乳增强免疫比浊法的快速粪便钙卫蛋白检测在炎症性肠病中的验证。
Sci Rep. 2024 Jan 18;14(1):1653. doi: 10.1038/s41598-024-51580-z.
2
Verification of the Bühlmann fCAL turbo faecal calprotectin assay on the Binding Site Optilite benchtop analyser.在Binding Site Optilite台式分析仪上对Bühlmann fCAL Turbo粪便钙卫蛋白检测法进行验证。
Pract Lab Med. 2023 Jun 24;36:e00318. doi: 10.1016/j.plabm.2023.e00318. eCollection 2023 Aug.
3
Changes in S100A8/A9 and S100A12 and Their Comparison with Other Analytes in the Saliva of Pigs with Diarrhea Due to .
因……导致腹泻的猪唾液中S100A8/A9和S100A12的变化及其与其他分析物的比较
Animals (Basel). 2023 Aug 8;13(16):2556. doi: 10.3390/ani13162556.
4
Measurement of Calprotectin (S100A8/A9) in the Saliva of Pigs: Validation Data of A Commercially Available Automated Assay and Changes in Sepsis, Inflammation, and Stress.猪唾液中钙卫蛋白(S100A8/A9)的测定:一种市售自动化检测方法的验证数据以及脓毒症、炎症和应激状态下的变化
Animals (Basel). 2023 Mar 29;13(7):1190. doi: 10.3390/ani13071190.
5
Composite Assessment Using Intestinal Ultrasound and Calprotectin Is Accurate in Predicting Histological Activity in Ulcerative Colitis: A Cohort Study.基于肠道超声和钙卫蛋白的综合评估可准确预测溃疡性结肠炎的组织学活动:一项队列研究。
Inflamm Bowel Dis. 2024 Feb 1;30(2):190-195. doi: 10.1093/ibd/izad043.
6
New Faecal Calprotectin Assay by IDS: Validation and Comparison to DiaSorin Method.IDS公司新型粪便钙卫蛋白检测法:验证及与DiaSorin方法的比较
Diagnostics (Basel). 2022 Sep 27;12(10):2338. doi: 10.3390/diagnostics12102338.
7
Comparing outcomes from tailored meta-analysis with outcomes from a setting specific test accuracy study using routine data of faecal calprotectin testing for inflammatory bowel disease.比较基于个体化荟萃分析的结果与基于常规粪便钙卫蛋白检测数据的特定研究场所炎症性肠病检测准确性研究的结果。
BMC Med Res Methodol. 2022 Jul 12;22(1):192. doi: 10.1186/s12874-022-01668-9.
8
Experimental infectious challenge in pigs leads to elevated fecal calprotectin levels following colitis, but not enteritis.对猪进行实验性感染攻击后,结肠炎会导致粪便钙卫蛋白水平升高,但肠炎不会。
Porcine Health Manag. 2021 Aug 24;7(1):48. doi: 10.1186/s40813-021-00228-9.
9
A comparison of diagnostic performance between two quantitative rapid fecal calprotectin assays in detecting active inflammatory bowel disease.两种定量粪便钙卫蛋白快速检测法诊断活动性炎症性肠病的比较。
PLoS One. 2021 Aug 12;16(8):e0255974. doi: 10.1371/journal.pone.0255974. eCollection 2021.
10
International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases.国际共识:炎症性肠病粪便钙卫蛋白检测标准化中的方法学问题。
United European Gastroenterol J. 2021 May;9(4):451-460. doi: 10.1002/ueg2.12069. Epub 2021 May 7.